Apria Inc is a medical instruments & supplies business based in the US. Apria Inc shares (APR) are listed on the NASDAQ and all prices are listed in US Dollars. Apria Inc employs 6,080 staff and has a trailing 12-month revenue of around $1.1 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $37.37 |
| 200-day moving average | $34.13 |
| Wall St. target price | $38.33 |
| PE ratio | 22.5904 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $1.66 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Apria Inc stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Apria Inc's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Apria Inc's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, Apria Inc shares trade at around 23x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Apria Inc's P/E ratio is best considered in relation to those of others within the medical instruments & supplies industry or those of similar companies.
Apria Inc's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $218 million.
The EBITDA is a measure of a Apria Inc's overall financial performance and is widely used to measure a its profitability.
To put Apria Inc's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $1.1 billion |
|---|---|
| Operating margin TTM | 9.4% |
| Gross profit TTM | $905 million |
| Return on assets TTM | 9.09% |
| Return on equity TTM | 96.92% |
| Profit margin | 5.66% |
| Book value | $1.12 |
| Market Capitalization | $1.3 billion |
TTM: trailing 12 months
We're not expecting Apria Inc to pay a dividend over the next 12 months.
You may also wish to consider:
Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. Apria, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana. As of March 29, 2022, Apria, Inc.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.